These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 17899074)

  • 21. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment.
    Mitchell CR; Lowe VJ; Rangel LJ; Hung JC; Kwon ED; Karnes RJ
    J Urol; 2013 Apr; 189(4):1308-13. PubMed ID: 23123372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First case of 18F-FACBC PET/CT-guided salvage retroperitoneal lymph node dissection for disease relapse after radical prostatectomy for prostate cancer and negative 11C-choline PET/CT: new imaging techniques may expand pioneering approaches.
    Schiavina R; Concetti S; Brunocilla E; Nanni C; Borghesi M; Gentile G; Cevenini M; Bianchi L; Molinaroli E; Fanti S; Martorana G
    Urol Int; 2014; 92(2):242-5. PubMed ID: 24334968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidental finding of parathyroid adenoma with 11C-choline PET/CT.
    Mapelli P; Busnardo E; Magnani P; Freschi M; Picchio M; Gianolli L; Messa C
    Clin Nucl Med; 2012 Jun; 37(6):593-5. PubMed ID: 22614195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer imaging with fluorine-18-labeled choline derivatives.
    Kwee SA; DeGrado TR; Talbot JN; Gutman F; Coel MN
    Semin Nucl Med; 2007 Nov; 37(6):420-8. PubMed ID: 17920349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.
    Krause BJ; Souvatzoglou M; Tuncel M; Herrmann K; Buck AK; Praus C; Schuster T; Geinitz H; Treiber U; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):18-23. PubMed ID: 17891394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ¹⁸F-NaF PET/CT and ¹¹C-Choline PET/CT for the initial detection of metastatic disease in prostate cancer: overview and potential utilization.
    Koo PJ; David Crawford E
    Oncology (Williston Park); 2014 Dec; 28(12):1057-62, 1064-5. PubMed ID: 25738199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there an additional value of ¹¹C-choline PET-CT to T2-weighted MRI images in the localization of intraprostatic tumor nodules?
    Van den Bergh L; Koole M; Isebaert S; Joniau S; Deroose CM; Oyen R; Lerut E; Budiharto T; Mottaghy F; Bormans G; Van Poppel H; Haustermans K
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1486-92. PubMed ID: 22284686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of penile metastases of prostatic origin with 11C-Choline PET/CT.
    Garcia JR; Aguilo JJ; Marco V; Valls E; Soler M; Lomeña F
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):295-6. PubMed ID: 22682926
    [No Abstract]   [Full Text] [Related]  

  • 29. Incidental 11C-choline PET/CT brain uptake due to meningioma in a patient studied for prostate cancer: correlation with MRI and imaging fusion.
    Bertagna F; Bosio G; Pinelli L; Treglia G; Giubbini R
    Clin Nucl Med; 2013 Nov; 38(11):e435-7. PubMed ID: 23698517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates.
    Krause BJ; Souvatzoglou M; Treiber U
    Urol Oncol; 2013 May; 31(4):427-35. PubMed ID: 21388835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [11C]choline PET/CT impacts treatment decision making in patients with prostate cancer referred for radiotherapy.
    Jereczek-Fossa BA; Rodari M; Bonora M; Fanti P; Fodor C; Pepe G; Lopci E; Zerini D; Vischioni B; Baroni G; Matei DV; De Cobelli O; Chiti A; Orecchia R
    Clin Genitourin Cancer; 2014 Jun; 12(3):155-9. PubMed ID: 24331577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
    Reske SN; Blumstein NM; Glatting G
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):9-17. PubMed ID: 17828534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.
    Rodado-Marina S; Coronado-Poggio M; García-Vicente AM; García-Garzón JR; Alonso-Farto JC; de la Jara AC; Maldonado-Suárez A; Rodríguez-Fernández A
    BJU Int; 2015 Jun; 115(6):874-83. PubMed ID: 25307619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms.
    Schiavina R; Scattoni V; Castellucci P; Picchio M; Corti B; Briganti A; Franceschelli A; Sanguedolce F; Bertaccini A; Farsad M; Giovacchini G; Fanti S; Grigioni WF; Fazio F; Montorsi F; Rigatti P; Martorana G
    Eur Urol; 2008 Aug; 54(2):392-401. PubMed ID: 18456393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-phase 11C-choline PET/computed tomography in the early evaluation of prostate cancer recurrence.
    Garcia JR; Cuberas G; Riera E; Soler M; Moragas M; Lomeña F
    Nucl Med Commun; 2015 Jan; 36(1):8-15. PubMed ID: 25299466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [11C]Choline-PET/CT for outcome prediction of salvage radiotherapy of local relapsing prostate carcinoma.
    Reske SN; Moritz S; Kull T
    Q J Nucl Med Mol Imaging; 2012 Oct; 56(5):430-9. PubMed ID: 23069922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choline PET/CT for prostate cancer: main clinical applications.
    Fuccio C; Rubello D; Castellucci P; Marzola MC; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e50-6. PubMed ID: 20800404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of (11)C-choline and (18)F-choline PET/CT for management of patients with prostate cancer.
    von Eyben FE; Kairemo K
    Nucl Med Commun; 2014 Mar; 35(3):221-30. PubMed ID: 24240194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of second tumors in 11C-choline PET/CT studies performed due to biochemical recurrence of prostate cancer].
    García JR; Ponce A; Canales M; Ayuso J; Moragas M; Soler M
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):28-31. PubMed ID: 23499124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDA approves 11C-choline for PET in prostate cancer.
    J Nucl Med; 2012 Dec; 53(12):11N. PubMed ID: 23203247
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.